Xin Hu

Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets

Yue Gong, Peng Ji, Yun‐Song Yang et al. · Cell Metabolism · 2020 · 467 citations · Full text

Tumor Biology, Breast Oncology, Medicine +10

Multi-Omics Profiling Reveals Distinct Microenvironment Characterization and Suggests Immune Escape Mechanisms of Triple-Negative Breast Cancer

Yi Xiao, Ding Ma, Shen Zhao et al. · Clinical Cancer Research · 2019 · 358 citations · Full text

The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer

Hai Wang, Xingyu Rong, Zhao Gan et al. · Cell Metabolism · 2022 · 346 citations · Full text

Breast Oncology, Medicine, Pharmacology +9

Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial

Yi-Zhou Jiang, Yin Liu, Yi Xiao et al. · Cell Research · 2020 · 298 citations · Full text

Comprehensive metabolomics expands precision medicine for triple-negative breast cancer

Yi Xiao, Ding Ma, Yun‐Song Yang et al. · Cell Research · 2022 · 297 citations · Full text